| Earnings (Loss) Per Share |
Note 10 - Earnings (Loss) Per Share The following tables set forth the computation of basic and diluted net income (loss) per share of common stock: | | | | | | | | | | | | | Three Months Ended June 30, | (in millions, except shares and per share amounts) | 2026 | | 2025 | | Basic net income (loss) per share attributable to common stockholders | | | | | Numerator: | | | | | Net income (loss) | $ | (643.7) | | | $ | 24.0 | | | Denominator: | | | | | Weighted average number of shares of common stock outstanding | 294,503,465 | | | 327,242,789 | | | Basic net income (loss) per share attributable to common stockholders | $ | (2.19) | | | $ | 0.07 | | | | | | | Diluted net income (loss) per share attributable to common stockholders | | | | | Numerator: | | | | | Net income (loss) | $ | (643.7) | | | $ | 24.0 | | | Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted average shares of common stock outstanding used to calculate diluted net income (loss) per share | 294,503,465 | | | 327,242,789 | | | Diluted net income (loss) per share attributable to common stockholders | $ | (2.19) | | | $ | 0.07 | |
| | | | | | | | | | | | | Six Months Ended June 30, | (in millions, except shares and per share amounts) | 2026 | | 2025 | | Basic net income (loss) per share attributable to common stockholders | | | | | Numerator: | | | | | Net income (loss) | $ | (614.4) | | | $ | 50.8 | | | Denominator: | | | | | Weighted average number of shares of common stock outstanding | 298,477,470 | | | 333,992,323 | | | Basic net income (loss) per share attributable to common stockholders | $ | (2.06) | | | $ | 0.15 | | | | | | | Diluted net income (loss) per share attributable to common stockholders | | | | | Numerator: | | | | | Net income (loss) | $ | (614.4) | | | $ | 50.8 | | | Denominator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted average shares of common stock outstanding used to calculate diluted net income (loss) per share | 298,477,470 | | | 333,992,323 | | | Diluted net income (loss) per share attributable to common stockholders | $ | (2.06) | | | $ | 0.15 | |
In periods of loss, the number of shares used to calculate diluted net income (loss) per share is the same as basic net income (loss) per share. Potentially dilutive securities excluded due to their anti-dilutive effect were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Restricted stock units | 22,369,079 | | | 17,305,281 | | | 18,251,642 | | | 15,459,826 | | | | | | | | | | | CEO Premium-Priced Performance Option | 9,678,000 | | | — | | | 9,678,000 | | | — | | | Liability-classified awards | 171,084 | | | — | | | 171,084 | | | — | | | Exercise of common stock options | 186,307 | | | 264,746 | | | 187,661 | | | 245,835 | | | Total anti-dilutive securities | 32,404,470 | | | 17,570,027 | | | 28,288,387 | | | 15,705,661 | |
For a description of the terms and conditions of these securities, refer to Note 13 – Equity-Based Compensation in our 2025 Form 10-K.
|